Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection

被引:63
作者
Jaffar, S
Wilkins, A
Ngom, PT
Sabally, S
Corrah, T
Bangali, JE
Rolfe, M
Whittle, HC
机构
[1] Univ London London Sch Hyg & Trop Med, Dept Trop & Infect Dis, Infect Dis Epidemiol Unit, London WC1E 7HT, England
[2] Royal Victoria Hosp, Banjul, Gambia
[3] MRC Labs, Fajara, Senegal
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1997年 / 16卷 / 05期
关键词
HIV-1; HIV-2; CD4; decline; pathogenesis; The Gambia;
D O I
10.1097/00042560-199712150-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Increasing evidence suggests that the pathogenesis of HIV-1 is different from that of HIV-2. Thus, we have measured, longitudinally at various times over a median follow-up of 2.1 years, the percentage CD4(+) cells of 94 patients infected with HIV-1 and 164 patients infected with HIV-2. The pattern of decline of CD4% over time was linear for patients with either infection. Multilevel statistical modeling techniques showed that after stratifying for HIV status, the rate of decline of CD4% was faster among patients who died than among those who survived (difference in rate of decline = 2.34% CD4(+) cells/year; p = 0.0002). After stratifying for survival status, the rate of decline was faster and less variable among patients infected with HIV-1 than among patients infected with HIV-2 (difference in rate of decline = 1.12% CD4(+) cells/year; p = 0.05). The proportion of patients who showed no fall in CD4(+) cells was higher in HIV-2 than in HIV-1 infection (p = 0.026). These data suggest fundamental differences between the two infections, with HIV-1 being more pathogenic resulting in a faster and more homogeneous rate of decline than HIV-2. In HIV-2 infection, disease in many patients progresses slowly, but in some the advance is just as fast as that in HIV-1 infection. The reasons for this marked heterogeneity need elucidation to understand the disease and to target therapeutic interventions against HIV-2 in those most at risk.
引用
收藏
页码:327 / 332
页数:6
相关论文
共 19 条
[1]   EPIDEMIOLOGY AND TRANSMISSION OF HIV-2 - WHY THERE IS NO HIV-2 PANDEMIC [J].
DECOCK, KM ;
ADJORLOLO, G ;
EKPINI, E ;
SIBAILLY, T ;
KOUADIO, J ;
MARAN, M ;
BRATTEGAARD, K ;
VETTER, KM ;
DOORLY, R ;
GAYLE, HD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (17) :2083-2086
[2]  
DONNELLY C, 1993, B MATH BIOL, V55, P731, DOI 10.1007/BF02460671
[3]  
Goldstein H., 2010, Multilevel statistical models, V4th
[4]   SLOWER HETEROSEXUAL SPREAD OF HIV-2 THAN HIV-1 [J].
KANKI, PJ ;
TRAVERS, KU ;
MBOUP, S ;
HSIEH, CC ;
MARLINK, RG ;
GUEYENDIAYE, A ;
SIBY, T ;
THIOR, I ;
HERNANDEZAVILA, M ;
SANKALE, JL ;
NDOYE, I ;
ESSEX, ME .
LANCET, 1994, 343 (8903) :943-946
[5]   IMMUNOLOGICAL COMPARISON OF HIV-1REACTIVE, HIV-2REACTIVE AND DUALLY-REACTIVE WOMEN DELIVERING IN ABIDJAN, COTE-DIVOIRE [J].
KESTENS, L ;
BRATTEGAARD, K ;
ADJORLOLO, G ;
EKPINI, E ;
SIBAILLY, T ;
DIALLO, K ;
GIGASE, PL ;
GAYLE, H ;
DECOCK, KM .
AIDS, 1992, 6 (08) :803-807
[6]  
LANG W, 1989, J ACQ IMMUN DEF SYND, V2, P63
[7]  
LEGUENNO BM, 1991, J ACQ IMMUN DEF SYND, V4, P421
[8]   Serial CD4 and CD8 T-lymphocyte counts and associated mortality in an HIV-2-infected population in Guinea-Bissau [J].
Lisse, IM ;
Poulsen, AG ;
Aaby, P ;
Knudsen, K ;
Dias, F .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1996, 13 (04) :355-362
[9]   REDUCED RATE OF DISEASE DEVELOPMENT AFTER HIV-2 INFECTION AS COMPARED TO HIV-1 [J].
MARLINK, R ;
KANKI, P ;
THIOR, I ;
TRAVERS, K ;
EISEN, G ;
SIBY, T ;
TRAORE, I ;
HSIEH, CC ;
DIA, MC ;
GUEYE, E ;
HELLINGER, J ;
GUEYENDIAYE, A ;
SANKALE, JL ;
NDOYE, I ;
MBOUP, S ;
ESSEX, M .
SCIENCE, 1994, 265 (5178) :1587-1590
[10]   EPIDEMIOLOGIC CHARACTERISTICS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 INFECTION IN AFRICA [J].
MIYAZAKI, M .
INTERNATIONAL JOURNAL OF STD & AIDS, 1995, 6 (02) :75-80